AllianceBernstein’s Intermolecular, Inc. IMI Stock Holding History

AllianceBernstein’s Portfolio IMI Stock Details IMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-13,181	Closed	-$37K	–	3732
2014 Q1	$37K	Sell	13,181 -11,200	-46%	-$40.8K	﹤0.01%	3156
2013 Q4	$120K	Sell	24,381 -5,200	-18%	-$29.4K	﹤0.01%	2899
2013 Q3	$163K	Sell	29,581 -1,119	-4%	-$7.03K	﹤0.01%	2900
2013 Q2	$223K	Buy	+30,700	New	+$261K	﹤0.01%	2812

Other funds holding IMI

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

AllianceBernstein's IMI Position: Q2 2014 in Review

AllianceBernstein sold out of Intermolecular, Inc. (IMI) in Q2 2014, closing a stake of 13,181 shares — an estimated $37K sold.

AllianceBernstein first reported a position in IMI in Q2 2013 and held it in 4 quarters. The position peaked at $223K in Q2 2013. 43 funds tracked by Wall St. Rank hold IMI as of Q2 2014.

AllianceBernstein reported no remaining Intermolecular, Inc. position as of Q2 2014 after selling out during the quarter.
AllianceBernstein sold 13,181 Intermolecular, Inc. shares in Q2 2014, an estimated $37K.
AllianceBernstein first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 4 quarters.
AllianceBernstein's Intermolecular, Inc. position peaked at $223K in Q2 2013.
43 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q2 2014.

Based on AllianceBernstein's 13F filing for Q2 2014, filed 13 Aug 2014.